» Articles » PMID: 31390028

Androgens During the Reproductive Years: What Is Normal for Women?

Overview
Specialty Endocrinology
Date 2019 Aug 8
PMID 31390028
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Whether serum androgen levels can identify women with "androgen insufficiency" or "androgen excess" is unresolved; thus, what constitutes "normal" remains uncertain. We sought to determine whether androgens, including 11-oxygenated C19 steroids, vary with age, menstrual cycle, or body mass index (BMI), during the reproductive years.

Design And Setting: Cross-sectional study recruited from eastern Australian states.

Participants: A total of 588 women, aged 18 to 39 years, who were not pregnant, lactating, or using systemic hormone therapy, with regular menstrual cycles and no previous diagnosis of polycystic ovarian syndrome.

Main Outcome Measures: Sex steroids measured using liquid chromatography-tandem mass spectrometry.

Results: Testosterone and androstenedione concentrations were significantly higher during the menstrual cycle mid- and luteal phases than in the early follicular phase, with median values across the cycle of 0.34 nmol/L (range, 0.04 to 1.01) and 1.97 nmol/L (range, 0.53 to 7.89), respectively. No cyclical variations were found in dehydroepiandrosterone (DHEA; 4.91 nmol/L; range, 0.08 to 23.51), 11-ketoandrostenedione (11KA; 7.99 nmol/L; range, 0.07 to 31.67), or 11-ketotestosterone (11KT; 1.27 nmol/L; range, 0.03 to 7.61). Overweight women had lower median testosterone (P < 0.05), DHEA (P < 0.05), and 11KA (P < 0.01) levels than normal-weight women. All C19 steroids were significantly lower (P < 0.01) in those aged 35 to 39 years than in those aged 18 to 25 years. The median 11KA/androstenedione (4.3:1) and 11KT/testosterone (3.9:1) ratios did not change with age, after adjustment for BMI and cycle stage.

Conclusions: We have demonstrated that 11KA and 11KT are stable across the menstrual cycle and make major quantitative contributions to the circulating androgen pool. All C19 androgens declined with age before menopause; hence, age-specific reference ranges are required for the interpretation of androgen levels in premenopausal women.

Citing Articles

Exploring the Predictive Role of 11-Oxyandrogens in Diagnosing Polycystic Ovary Syndrome.

Mody A, Lodish M, Auchus R, Turcu A, Jiang F, Huddleston H Endocrinol Diabetes Metab. 2025; 8(1):e70022.

PMID: 39815717 PMC: 11735743. DOI: 10.1002/edm2.70022.


The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin levels: A secondary study from the WHICH randomized clinical trial.

Avenant C, Singata-Madliki M, Bick A, Africander D, Balakrishna Y, Storbeck K PLoS One. 2024; 19(8):e0307736.

PMID: 39178280 PMC: 11343371. DOI: 10.1371/journal.pone.0307736.


Human-like adrenal features in Chinese tree shrews revealed by multi-omics analysis of adrenal cell populations and steroid synthesis.

Jiang J, Wang Y, Zheng J, Lei Y, Chen Z, Guo Y Zool Res. 2024; 45(3):617-632.

PMID: 38766745 PMC: 11188597. DOI: 10.24272/j.issn.2095-8137.2023.280.


Longitudinal assessment of classic and 11-oxygenated androgen concentrations and their association with type 2 diabetes mellitus development: the Tromsø study.

Allaoui G, Rylander C, Fuskevag O, Grimnes G, Averina M, Wilsgaard T Acta Diabetol. 2024; 61(7):847-857.

PMID: 38498076 PMC: 11182793. DOI: 10.1007/s00592-024-02266-5.


Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study.

Davis S, Azene Z, Tonkin A, Woods R, McNeil J, Islam R Climacteric. 2024; 27(3):282-288.

PMID: 38345304 PMC: 11196127. DOI: 10.1080/13697137.2024.2310530.